keyword
Keywords Urinary tract infections proph...

Urinary tract infections prophylaxys

https://read.qxmd.com/read/38650404/-antibacterial-prophylaxis-with-fosfomycin-at-the-time-of-the-urethral-catheter-removal-after-radical-prostatectomy-prospective-randomized-trial
#1
JOURNAL ARTICLE
I Veliev E, A Sokolov E, Yu Metelev A, N Aliev E, S Polyakova A, V Ivkin E
AIM: To evaluate the effect of antibacterial prophylaxis using oral fosfomycin during the removal of a urethral catheter after radical prostatectomy on the development of urinary tract infection, severity of leukocyturia and bacteriuria, as well as the severity of lower urinary tract symptoms. MATERIALS AND METHODS: A single-center, non-blind, prospective, randomized controlled trial was carried out. The main group included 40 patients, and the control group included 37 patients...
March 2024: Urologii︠a︡
https://read.qxmd.com/read/38637262/randomized-clinical-trial-of-non-antibiotic-prophylaxis-with-d-mannose-plus-proanthocyanidins-vs-proanthocyanidins-alone-for-urinary-tract-infections-and-asymptomatic-bacteriuria-in-de-novo-kidney-transplant-recipients-the-manotras-study
#2
JOURNAL ARTICLE
Melissa Rau, Adrian Santelli, Sara Martí, María Isabel Díaz, Nuria Sabé, María Fiol, Luis Riera, Begoña Etcheverry, Sergi Codina, Ana Coloma, Anna Carreras-Salinas, Carmen Ardanuy, Josep M Cruzado, Edoardo Melilli
BACKGROUND: Studies analyzing non-antibiotic alternatives in kidney transplant UTI's are lacking. d-Mannose, a simple sugar, inhibits bacterial attachment to the urothelium, as does Proanthocyanidins; both could act as a synergic strategy preventing UTI; nonetheless their efficacy and safety have not been evaluated in kidney transplant population yet. METHODS: This is a pilot prospective, double-blind randomized trial. Sixty de novo kidney transplant recipients were randomized (1:1) to receive a prophylactic strategy based on a 24-h prolonged release formulation of d-Mannose plus Proanthocyanidins vs...
April 17, 2024: Nefrología
https://read.qxmd.com/read/38626728/ureterorenoscopic-stone-removal-without-antibiotic-prophylaxis
#3
JOURNAL ARTICLE
Maximilian Reinhard Müller, Eva-Maria Prey, Philipp Julian Spachmann, Christopher Goßler, Maximilian Burger, Marco Julius Schnabel
Purpose To assess the feasibility of sparing routine antibiotic prophylaxis in patients without preoperative urinary tract infection (UTI) undergoing a ureterorenoscopy (URS) for stone removal. Patients and Methods A retrospective, monocentric study was conducted to evaluate the outcome of a modified perioperative antibiotic management strategy according to the principles of antibiotic stewardship (ABS). Patients with preoperative unremarkable urine culture received no antibiotic prophylaxis for ureterorenoscopic stone removal (NoPAP)...
April 16, 2024: Urologia Internationalis
https://read.qxmd.com/read/38621856/finding-the-best-subgroup-with-differential-treatment-effect-with-multiple-outcomes
#4
JOURNAL ARTICLE
Beibo Zhao, Jason Fine, Anastasia Ivanova
Precision medicine aims to identify specific patient subgroups that may benefit the most from a particular treatment than the whole population. Existing definitions for the best subgroup in subgroup analysis are based on a single outcome and do not consider multiple outcomes; specifically, outcomes of different types. In this article, we introduce a definition for the best subgroup under a multiple-outcome setting with continuous, binary, and censored time-to-event outcomes. Our definition provides a trade-off between the subgroup size and the conditional average treatment effects (CATE) in the subgroup with respect to each of the outcomes while taking the relative contribution of the outcomes into account...
April 15, 2024: Statistics in Medicine
https://read.qxmd.com/read/38619922/venous-thromboembolism-risk-factors-in-women-with-obesity-who-undergo-cesarean-delivery
#5
JOURNAL ARTICLE
Tolulope B Fatokun, Sarah E Swartz, Ahmed Ebeid, Sophia A Cordes, Alexis C Gimovsky, Andrew D Sparks, Richard L Amdur, Homa K Ahmadzia
Venous thromboembolism (VTE) is a leading cause of maternal mortality. Obesity and cesarean delivery are established risk factors for pregnancy-related VTE. We identified additional risk factors among patients with obesity who underwent a cesarean delivery to identify those who need VTE prophylaxis. We conducted a secondary analysis of data from the Maternal-Fetal Medicine Units Network (MFMU) Cesarean Registry Database using a case-control design. Cases were identified as women with obesity having a pre-pregnancy body mass index of >30 kg/m2 , who underwent cesarean delivery and subsequently developed deep venous thrombosis (DVT) or pulmonary embolism (PE)...
2024: Clinical and Applied Thrombosis/hemostasis
https://read.qxmd.com/read/38587819/d-mannose-for-prevention-of-recurrent-urinary-tract-infection-among-women-a-randomized-clinical-trial
#6
JOURNAL ARTICLE
Gail Hayward, Sam Mort, Alastair D Hay, Michael Moore, Nicholas P B Thomas, Johanna Cook, Jared Robinson, Nicola Williams, Nicola Maeder, Rebecca Edeson, Marloes Franssen, Jenna Grabey, Margaret Glogowska, Yaling Yang, Julie Allen, Christopher C Butler
IMPORTANCE: Recurrent urinary tract infection (UTI) is a common debilitating condition in women, with limited prophylactic options. d-Mannose has shown promise in trials based in secondary care, but effectiveness in placebo-controlled studies and community settings has not been established. OBJECTIVE: To determine whether d-mannose taken for 6 months reduces the proportion of women with recurrent UTI experiencing a medically attended UTI. DESIGN, SETTING, AND PARTICIPANTS: This 2-group, double-blind randomized placebo-controlled trial took place across 99 primary care centers in the UK...
April 8, 2024: JAMA Internal Medicine
https://read.qxmd.com/read/38587242/antibiotic-prophylaxis-in-invasive-urodynamics-a-delphi-consensus-of-the-italian-society-of-urodynamics-siud
#7
JOURNAL ARTICLE
Emanuele Rubilotta, Elisabetta F Chiarulli, Enrico Ammirati, Marianna C Bevacqua, Stefano Manodoro, Stefania Chierchia, Eugenia Fragalà, Giuseppe Masiello, Vincenzo L Marzi, Alessandro Giammò, Stefania Musco, Francesco Savoca, Matteo Balzarro, Cosimo De Nunzio, Gaetano De Rienzo, Ferdinando Fusco, Gianfranco Lamberti, Marco Soligo, Luisa De Palma, Massimo Fasano, Anna Carretta, Fabio Tumietto, Enrico Finazzi-Agrò, Eleonora Russo, Alessandro Antonelli, Marilena Gubbiotti, Gianluca Sampogna, Michele Spinelli, Roberto Carone, Leonardo Martino, Vito Mancini
INTRODUCTION: Although antibiotic prophylaxis (AB) demonstrated a statistically significant reduction in bacteriuria after invasive urodynamics (UDS), no significant decrease in the incidence of urinary tract infections (UTI) has been confirmed. No absolute recommendations on the use of AB in case of relevant potential risk of UTI have been reported, though some categories of patients at increased infective probability after UDS have been recognized. The aim of this study is to report the experts' consensus on the best practice for the use of AB before UDS in the main categories of patients at potential risk of developing UTI...
April 8, 2024: Neurourology and Urodynamics
https://read.qxmd.com/read/38585593/reducing-recurrent-urinary-tract-infections-in-women-with-mv140-impacts-personal-burden-of-disease-secondary-analyses-of-a-randomized-placebo-controlled-efficacy-study
#8
JOURNAL ARTICLE
J Curtis Nickel, Stephen Foley, Bob Yang, Miguel Casanovas, Raquel Caballero, Carmen María Diez-Rivero, María-Fernanda Lorenzo-Gómez
BACKGROUND: Recurrent urinary tract infection (rUTI) remains a major health burden for women. A randomized, double-blind, placebo-controlled trial (RCT; NCT02543827) reported that female patients with rUTI receiving a sublingual vaccine, MV140, had a reduction in rUTI and increase in UTI-free rate compared with placebo. OBJECTIVE: To determine the impact of MV140 on the personal burden of disease in women with rUTI using secondary endpoint data from the pivotal RCT evaluating MV140...
May 2024: European urology open science
https://read.qxmd.com/read/38537707/prevalence-of-antimicrobial-use-and-healthcare-associated-infections-in-the-uae-results-from-the-first-nationwide-point-prevalence-survey
#9
JOURNAL ARTICLE
Najiba Abdulrazzaq, Ayman Chkhis
OBJECTIVES: The WHO's Global Antimicrobial Resistance Surveillance System (GLASS) 2017-2018 reported a significant increase in antimicrobial resistance among nosocomial pathogens. This was the first national point of prevalence survey in United Arab Emirates. METHODS: A one-day multicenter cross-sectional survey using a unified web-based platform was conducted in forty-four hospitals across the country from 3 to 23 November 2019 to estimate the prevalence of antimicrobial use and healthcare-associated infections among both governmental and private sectors...
March 25, 2024: Infectious diseases now
https://read.qxmd.com/read/38523904/infectious-complications-of-transrectal-prostate-biopsy-in-patients-receiving-targeted-antibiotic-prophylaxis-after-urethral-and-rectal-swab-versus-standard-prophylaxis-a-prospective-comparative-study
#10
JOURNAL ARTICLE
Sotirios Gatsos, Nikolaos Kalogeras, Georgios Dimakopoulos, Michael Samarinas, Anna Papakonstantinou, Efi Petinaki, Vassilios Tzortzis, Stavros Gravas
BACKGROUND: To evaluate the role of targeted antibiotic prophylaxis (TAP) after rectal and urethral swab cultures compared to empiric antibiotic prophylaxis (EAP) for the prevention of infectious complications after transrectal ultrasound-guided prostate biopsy (TRUS-Bx). METHODS: We conducted a prospective comparative study on 141 patients who underwent TRUS-Bx and were allocated in two groups. The first group (n = 71) received EAP with ciprofloxacin and the second (n = 70) received TAP according to rectal and urethral cultures...
March 2024: Prostate International
https://read.qxmd.com/read/38501377/optimizing-practices-to-prevent-urinary-tract%C3%A2-infection-after-cystoscopy-and-urodynamics-in-women-a-quality-improvement-study
#11
JOURNAL ARTICLE
Anouk Benseler, George Tomlinson, Danny Lovatsis, May Alarab, Colleen D McDermott
OBJECTIVE: The objective of this study was to reduce the incidence of urinary tract infection (UTI) in women undergoing outpatient cystoscopy and/or urodynamic studies (UDS) at our centre by identifying and then altering modifiable risk factors through an analysis of incidence variability among physicians. METHODS: This was a quality improvement study involving adult women undergoing outpatient cystoscopy and/or UDS at an academic tertiary urogynecology practice...
March 19, 2024: Neurourology and Urodynamics
https://read.qxmd.com/read/38484242/antibiotics-for-uti-prevention-after-intradetrusor-onabotulinumtoxina-injections
#12
JOURNAL ARTICLE
Christopher W Heuer, Jordan D Gisseman, Christine M Vaccaro, Cara H Olsen, Alissa C Galgano, Katherine L Dengler
IMPORTANCE: Urinary tract infections (UTIs) occur in 8.6% to 48.1% of patients after intradetrusor onabotulinumtoxinA injections. OBJECTIVE: The objective of this study was to evaluate both choice and duration of antibiotic prophylaxis on the incidence of UTI within 30 days after in-office onabotulinumtoxinA injections. STUDY DESIGN: We included a single-site, retrospective cohort of 305 patients with overactive bladder or bladder pain syndrome receiving postprocedure prophylactic antibiotics for in-office, 100-unit intradetrusor onabotulinumtoxinA injections from 2019 to 2023...
March 1, 2024: Urogynecology (Phila)
https://read.qxmd.com/read/38466864/microbiology-of-infection-related-complications-after-transrectal-ultrasound-guided-prostate-biopsy
#13
JOURNAL ARTICLE
Cynthia T Nguyen, Alison Lew, Natasha N Pettit, Jennifer Pisano, Luke F Reynolds
INTRODUCTION: The objective of this study was to describe the incidence, microbiology, and risk factors related to infectious complications after transrectal prostate biopsies. METHODS: This was a single-center, retrospective cohort study of patients undergoing prostate biopsies. Throughout the study period, the institutional standard for antibiotic prophylaxis was cephalexin and ciprofloxacin. Due to the desire to limit fluoroquinolone use, the ciprofloxacin duration of therapy was reduced from 48 to 24 hours in the middle of the study period...
March 1, 2024: Canadian Urological Association Journal
https://read.qxmd.com/read/38463548/impact-of-early-rejection-treatment-on-infection-development-in-kidney-transplant-recipients-a-propensity-analysis
#14
JOURNAL ARTICLE
Simran Gupta, Juan Gea-Banacloche, Raymond L Heilman, Reena N Yaman, Hay Me Me, Nan Zhang, Holenarasipur R Vikram, Lavanya Kodali
INTRODUCTION: The impact of renal allograft rejection treatment on infection development has not been formally defined in the literature. METHODS: We conducted a retrospective cohort study of 185 rejection (case) and 185 nonrejection (control) kidney transplant patients treated at our institution from 2014 to 2020 to understand the impact of rejection on infection development. Propensity scoring was used to match cohorts. We collected data for infections within 6 months of rejection for the cases and 18 months posttransplant for controls...
2024: Journal of Transplantation
https://read.qxmd.com/read/38448785/antimicrobial-prophylaxis-protocol-based-on-rectal-swab-culture-before-prostate-biopsy-to-prevent-infectious-complications-a-prospective-randomized-comparative-study
#15
JOURNAL ARTICLE
A Bouzouita, A Rehaiem, A Saadi, S Zaghbib, M Chakroun, H Ayed, A Ferjani, A Derouiche, I Boutiba-Ben Boubaker, M R Ben Slama
PURPOSE: To evaluate the benefit of targeted antibiotic prophylaxis (TAP) based on rectal swab culture in comparison with standard empiric antimicrobial prophylaxis in patients undergoing transrectal ultrasound-guided needle biopsy of the prostate (TRUS-BP), as well as to assess rate of fecal carriage of Fluoroquinolone-resistant Enterobacterales FQRE. PATIENTS AND METHODS: We prospectively analyzed data that randomized 157 patients within two groups: (G1) TAP according to rectal swab performed 10 days before PB; (G2): empirical antibiotic prophylaxis with ciprofloxacin...
March 7, 2024: International Urology and Nephrology
https://read.qxmd.com/read/38447214/health-care-workers-online-youtube-content-compared-to-aua-prevention-of-recurrent-urinary-tract-infections-in-women-guidelines-an-integrative-review-of-quality-and-comprehensiveness-analysis
#16
JOURNAL ARTICLE
Mostafa Bondok, Lynn Stothers, Andrew Macnab, Mohamed Bondok, A Lenore Ackerman, Emma Dixon, Marcia Trochez, Kelsey Petersen, Rishika Selvakumar
INTRODUCTION: We document the quality, veracity, and comprehensiveness of recurrent UTI information on YouTube to increase health care workers' (HCWs') awareness of UTI-related content online, and to identify deficits in understanding, clarify misconceptions, and reduce stigmatization risk. METHODS: High-traffic topic search terms were curated by Google Trends to extract 200 videos, of which 45 met inclusion criteria. Five independent reviewers used a standardized questionnaire based on the AUA recurrent UTI guidelines to assess the definition of UTI, marketing content, prophylaxis/prevention strategies, and antibiotic use/stewardship...
February 28, 2024: Urology Practice
https://read.qxmd.com/read/38441661/primary-non-refluxing-megaureter-natural-history-follow-up-and-treatment
#17
REVIEW
Giulio Rivetti, Pierluigi Marzuillo, Stefano Guarino, Anna Di Sessa, Angela La Manna, Anthony A Caldamone, Alfonso Papparella, Carmine Noviello
UNLABELLED: Primary non-refluxing megaureter (PMU) is a congenital dilation of the ureter which is not related to vesicoureteral reflux, duplicated collecting systems, ureterocele, ectopic ureter, or posterior urethral valves and accounts for 5 to 10% of all prenatal hydronephrosis (HN) cases. The etiology is a dysfunction or stenosis of the distal ureter. Most often PMU remains asymptomatic with spontaneous resolution allowing for non-operative management. Nevertheless, in selective cases such as the development of febrile urinary tract infections, worsening of the ureteral dilatation, or reduction in relative renal function, surgery should be considered...
March 5, 2024: European Journal of Pediatrics
https://read.qxmd.com/read/38426237/effect-of-increasing-age-and-ureteral-stent-implantation-on-urinary-tract-infections-after-kidney-transplantation-update-of-recent-literature
#18
JOURNAL ARTICLE
Haris Omic, Michael Eder
PURPOSE OF REVIEW: This review aims to present the recent literature regarding effects of aging and ureteral stent implantation (UrS) on the risk of urinary tract infections (UTIs) in kidney transplant (KTX) recipients. RECENT FINDINGS: UTIs in kidney transplant recipients remain a clinical challenge and represent a leading cause of morbidity, hospitalization rates, and mortality. Higher age was described as a significant risk factor for UTIs in several studies including a recent Brazilian analysis, indicating a 3...
March 1, 2024: Current Opinion in Urology
https://read.qxmd.com/read/38393801/acute-uncomplicated-utis-in-adults-rapid-evidence-review
#19
JOURNAL ARTICLE
Peter K Kurotschka, Ildikó Gágyor, Mark H Ebell
An acute uncomplicated urinary tract infection (UTI) is a bacterial infection of the lower urinary tract with no sign of systemic illness or pyelonephritis in a noncatheterized, nonpregnant adult with no urologic abnormalities or immunocompromise. In women, a self-diagnosis of a UTI with the presence of typical symptoms (e.g., frequency, urgency, dysuria/burning sensation, nocturia, suprapubic pain), without vaginal discharge, is accurate enough to diagnose an uncomplicated UTI without further testing. Urine culture and susceptibility testing should be reserved for women with recurrent infection, treatment failure, history of resistant isolates, or atypical presentation to make a definitive diagnosis and guide antibiotic selection...
February 2024: American Family Physician
https://read.qxmd.com/read/38391262/antibiotic-prophylaxis-with-urodynamic-studies-in-spinal-cord-injury-assessing-practice-patterns-and-outcomes-to-guide-future-practice-in-a-single-center
#20
JOURNAL ARTICLE
Du Pham, Bradley Chi, Felicia Skelton, Donna Huang
CONTEXT/OBJECTIVE: Despite urinary tract infections (UTIs) being a common problem in patients with spinal cord injuries (SCIs), and a well-known complication of invasive urologic procedures, little consensus exists regarding the standard of care for peri-procedural antibiotic use for SCI patients undergoing urodynamics studies (UDS). Our research seeks to evaluate local antibiotic prophylaxis pattern in SCI patients undergoing UDS, assess incidence of post-procedural UTI, describe local antibiotic resistance trends, and provide antibiotic stewardship considerations to guide future practice...
February 23, 2024: Journal of Spinal Cord Medicine
keyword
keyword
116956
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.